Advanced Medical Isotope Corp. (OTCBB: ADMD)

CEO James C. Katzaroff called into to go over the details of the Company’s recently released exciting news. AMIC announced an exclusive license with Batelle earlier in April 2012 that included eight patents pertaining to the injectable radiogel. We believe utilizing the skill set of our in-house scientists, in conjunction with the outstanding personnel at Pacific Northwest National Laboratory, will foster outstanding results as the advantages of the Yttrium-90 radiogel line become fully defined and deployed.

Advanced Medical Isotope Corporation (OTCBB: ADMD) is a U.S.-based public company engaged in the production and distribution of medical isotopes and in the development and identification of medical isotope technologies that are changing the practice of medicine and revolutionizing the standard of available medical care.